[Intra-aortic balloon counterpulsation: first clinical experiences (author's transl)]

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Context:

• Acute myocardial infarction (AMI) remains a leading cause of mortality.
• Complications such as cardiogenic shock and refractory heart failure significantly worsen prognosis.
• Intra-aortic balloon counterpulsation (IABP) is a mechanical circulatory support device used in high-risk cardiac conditions.

Purpose:

• To report on the use of intra-aortic balloon counterpulsation (IABP) in three distinct cases of acute myocardial infarction with severe complications.
• To evaluate the efficacy and outcomes of IABP therapy in patients with cardiogenic shock, pulmonary edema, and refractory left heart failure.
• To analyze the potential benefits and risks associated with IABP in the management of acute myocardial infarction.

Summary:

• Three patients with acute myocardial infarction (AMI) complicated by cardiogenic shock, pulmonary edema, or refractory left heart failure were treated with intra-aortic balloon counterpulsation (IABP).
• Two patients initially showed prompt clinical improvement with hemodynamic stabilization and resolution of heart failure symptoms.
• Despite initial benefits, one patient succumbed to extensive myocardial damage, and another to a hemorrhagic complication; the third patient demonstrated significant hemodynamic improvement and was discharged.

Impact:

• IABP can provide temporary hemodynamic support, improving outcomes in select AMI patients with severe complications.
• The management of AMI with IABP requires careful consideration of potential complications, including bleeding.
• Successful IABP use can lead to recovery and discharge for some critically ill patients, highlighting its therapeutic role.